Skip to content
Open access · CC-BY via OpenAlex

Epigenetic alterations in depression and antidepressant treatment

Andreas Menke, Elisabeth B. Binder

Dialogues in Clinical Neuroscience · 2014 · ▲ 165 citations

Abstract

Epigenetic modifications control chromatin structure and function, and thus mediate changes in gene expression, ultimately influencing protein levels. Recent research indicates that environmental events can induce epigenetic changes and, by this, contribute to long-term changes in neural circuits and endocrine systems associated with altered risk for stress-related psychiatric disorders such as major depression. In this review, we describe recent approaches investigating epigenetic modifications associated with altered risk for major depression or response to antidepressant drugs, both on the candidate gene levels as well as the genome-wide level. In this review we focus on DNA methylation, as this is the most investigated epigenetic change in depression research.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.31887/dcns.2014.16.3/amenke
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Menke, A., &amp; Binder, E.B. (2014). Epigenetic alterations in depression and antidepressant treatment. <em>Dialogues in Clinical Neuroscience</em>. https://doi.org/10.31887/dcns.2014.16.3/amenke
Vancouver
Menke A, Binder EB. Epigenetic alterations in depression and antidepressant treatment. Dialogues in Clinical Neuroscience. 2014. doi:10.31887/dcns.2014.16.3/amenke.
BibTeX
@article{andreas2014Epigen, title = {Epigenetic alterations in depression and antidepressant treatment}, author = {Andreas Menke and Elisabeth B. Binder}, journal = {Dialogues in Clinical Neuroscience}, year = {2014}, doi = {10.31887/dcns.2014.16.3/amenke}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings